M. Garcia-Marquez

发表

Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma

A. Quaas, D. Beutner, S. Theurich, 2017, Oncotarget.

Using Antigen-Specific B Cells to Combine Antibody and T Cell–Based Cancer Immunotherapy

M. Hallek, S. Theurich, A. Shimabukuro-Vornhagen, 2017, Cancer Immunology Research.

Vaccination with dendritic cell-tumor fusion cells in multiple myeloma patients: a promising strategy?

S. Theurich, A. Shimabukuro-Vornhagen, M. von Bergwelt-Baildon, 2013, Immunotherapy.

Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic markers in non-small cell lung cancer

A. Grabowska, D. Onion, A. Reece-Smith, 2017, Oncotarget.

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.

A. Rosenwald, W. Klapper, J. Richter, 2020, Blood.

Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma

T. Schmid, S. Theurich, M. von Bergwelt-Baildon, 2016, Cancer Immunology Research.

In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide Spanish database

H. Bueno, S. Raposeiras-Roubín, Á. Cequier, 2020, Cardiology journal.

Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma

A. Rosenwald, W. Klapper, A. Diepstra, 2021, Leukemia.

A multimerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B cells.

S. Theurich, A. Shimabukuro-Vornhagen, M. von Bergwelt-Baildon, 2014, Cytotherapy.

Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma

T. Zander, M. Hallek, D. Stippel, 2016, Oncoimmunology.

T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option.

M. von Bergwelt-Baildon, A. Nowag, O. Cornely, 2021, The Journal of infection.

In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy

W. Bloch, A. Shimabukuro-Vornhagen, M. von Bergwelt-Baildon, 2015, Oncoimmunology.

Characterization of tumor-associated B-cell subsets in patients with colorectal cancer

M. Hallek, D. Stippel, A. Hölscher, 2014, Oncotarget.

Complex interactions between B cells and dendritic cells.

A. Shimabukuro-Vornhagen, M. von Bergwelt-Baildon, M. Garcia-Marquez, 2013, Blood.

P06.05 Endogenous T-cell responses to ten major cancer testis antigens are frequent in esophago-gastric adenocarcinoma and antigen-specific T cells can be expanded using CD40-activated B cells

M. von Bergwelt-Baildon, H. Schlößer, M. Thelen, 2021, Journal for ImmunoTherapy of Cancer.

Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells

A. Hillmer, M. von Bergwelt-Baildon, S. Chon, 2022, Journal for ImmunoTherapy of Cancer.

Immunological effects in patients with steroid‐refractory graft‐versus‐host disease following treatment with basiliximab, a CD25 monoclonal antibody

M. Hallek, S. Theurich, A. Shimabukuro-Vornhagen, 2016, European journal of haematology.

Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy

K. Hekmat, A. Quaas, D. Beutner, 2021, npj Precision Oncology.

CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses

A. Quaas, S. Eidt, A. Shimabukuro-Vornhagen, 2021, Cancer Immunology Research.

Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma

T. Zander, A. Quaas, D. Stippel, 2020, Cancer Immunology, Immunotherapy.

B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies

T. Zander, A. Quaas, A. Hölscher, 2018, Oncoimmunology.

Prospective Analyses of Circulating B Cell Subsets in ABO‐Compatible and ABO‐Incompatible Kidney Transplant Recipients

D. Stippel, V. Ditt, A. Shimabukuro-Vornhagen, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Antigen‐presenting human B cells are expanded in inflammatory conditions

M. Hallek, M. Herling, S. Theurich, 2017, Journal of leukocyte biology.

CD40-activated B cells induce anti-tumor immunity in vivo

S. Theurich, A. Shimabukuro-Vornhagen, M. von Bergwelt-Baildon, 2016, Oncotarget.

Percutaneous and surgical aortic valve replacement. Impact of volume and type of center on results

José Luis Bernal, A. Íñiguez, C. Macaya, 2020 .

Regulatory B10 cells display an altered homoeostasis in acute graft‐versus‐host disease

M. Hallek, S. Theurich, A. Shimabukuro-Vornhagen, 2017, European journal of haematology.

Characteristics and outcomes of percutaneous coronary interventions in patients with spontaneous coronary artery dissection. A study from the administrative minimum data set of the Spanish National Health System

José Luis Bernal, C. Fernández-Pérez, M. García-Guimarães, 2022, Frontiers in Cardiovascular Medicine.

The effect of weekends and public holidays on the care of acute coronary syndrome in the Spanish National Health System.

A. Fernández-Ortiz, I. Nuñez-Gil, A. Viana Tejedor, 2022, Revista espanola de cardiologia.

T-cell development and activation in humanized mice lacking mouse major histocompatibility complexes

R. Stripecke, S. Talbot, Daniel Bachurski, 2024, bioRxiv.

Germline homozygosity and allelic imbalance of HLA-I are common in esophagogastric adenocarcinoma and impair the repertoire of immunogenic peptides

M. Peifer, K. Wennhold, L. Maas, 2024, Journal for ImmunoTherapy of Cancer.

Results of a Phase II clinical trial with Id-protein-loaded dendritic cell vaccine in multiple myeloma: encouraging or discouraging?

M. von Bergwelt-Baildon, A. Draube, K. Wennhold, 2012, Immunotherapy.